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Purpose: A new spirometric reference equation was recently developed from the 
first national chronic obstructive pulmonary disease (COPD) survey in Korea. How-
ever, Morris’ equation has been preferred for evaluating spirometric values instead. 
The objective of this study was to evaluate changes in severity staging in Korean 
COPD patients by adopting the newly developed Korean equation. Materials and 
Methods: We evaluated the spirometric data of 441 COPD patients. The presence of 
airflow limitation was defined as an observed post-bronchodilator forced expiratory 
volume in one second/forced vital capacity (FEV1/FVC) less than 0.7, and the sever-
ity of airflow limitation was assessed according to GOLD stages. Spirometric values 
were reassessed using the new Korean equation, Morris’ equation and other refer-
ence equations. Results: The severity of airflow limitation was differently graded in 
143 (32.4%) patients after application of the new Korean equation when compared 
with Morris’ equation. All 143 patients were reallocated into more severe stages (49 
at mild stage, 65 at moderate stage, and 29 at severe stage were changed to moder-
ate, severe and very severe stages, respectively). Stages according to other reference 
equations were changed in 18.6-49.4% of the patients. Conclusion: These results in-
dicate that equations from different ethnic groups do not sufficiently reflect the air-
flow limitation of Korean COPD patients. The Korean reference equation should be 
used for Korean COPD patients in order to administer proper treatment.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is characterized by airflow limita-
tion which is not fully reversible.1 Spirometry is essential for diagnosis and provides 
a useful description of the severity of pathological changes in COPD patients. The 
ratio of forced expiratory volume in one second (FEV1) to forced vital capacity 
(FVC) is useful to detect the presence of airflow limitation. Currently, a specific spi-Yong Il Hwang, et al.
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hospitals affiliated with Hallym University Medical School, 
in Korea. Stable COPD patients who visited any of the five 
hospitals and took the spirometry test at least one time in 
2006 were enrolled. The presence of airflow limitation was 
defined as observed post-bronchodilator FEV1/FVC less 
than 0.7. Patients who showed parenchymal change such as 
lung fibrosis and volume loss or pleural thickening upon 
chest radiography were excluded. Patients with bronchiec-
tasis were also excluded.  
Methods
Each of the five hospitals used the same type of spirometer 
for all subjects. Spirometry was performed by specially 
trained technicians according to the 1994 American Thorac-
ic Society recommendations.7 The study protocol was ap-
proved by the ethics committee of Hallym University Sa-
cred Heart Hospital, in Anyang, Korea.
We applied the new Korean spirometric equation to all 
subjects. We evaluated the change of disease severity by 
adopting the new Korean equation in COPD patients and 
obtained new predictive spirometric values. We were thus 
were able to reclassify the disease severity.
We also applied another five western reference equations 
to our study subjects. We compared the disease severities of 
each reference equation. The severity of airflow obstruction 
was classified according to the GOLD guidelines. The ref-
erence equations used in this study are shown in Table 1.8-12
All data are expressed as means and standard deviations 
or frequencies. A chi-square test was performed to assess 
rometric cut-point (e.g. post-bronchodilator FEV1/FVC <0.7) 
has been used for diagnosing COPD, after the Global Initia-
tive for Chronic Obstructive Lung Disease was introduced.2,3 
GOLD recommended a simple classification of disease se-
verity into 4 stages based on airflow limitation using the spe-
cific FEV1 cut-points (e.g. <80, 50, or 30% predicted).1
Interpretation of spirometry is based on comparisons of 
data obtained in an individual patient or subject with refer-
ence (predicted) values. Ideally, the reference values are 
calculated with equations derived from measurements ob-
served in a representative sample of healthy subjects in a 
general population.4 Morris’ reference equation, which was 
derived from a large number of Mormons,5 has been used 
as a reference equation for spirometry in Korea.
Recently, a new reference equation for spirometry was 
developed from the first national COPD survey in Korea. 
The survey was conducted in conjunction with the second 
Korean National Health and Nutrition Examination Survey 
(Korean NHANES II).6 Notwithstanding, Morris’ equation 
is still used for spirometric reference values. The objective 
of this study was to evaluate changes in disease severity stag-
ing among Korean COPD patients by adopting the newly 
developed Korean equation.
MATERIALS AND METHODS
　　　
Study subjects
We constructed a COPD patient cohort retrospectively in 5 
Table 1. Reference Equations Examined in the Present Study
FVC (male) FVC (female)
Korean
6  0.05292H+0.010947W-0.00008633A
2
  -4.8434
0.03951H+0.006892W-0.00012728A
2
  -3.0006
Morris, et al.
5 0.3937*×0.148H-0.025A-4.241 0.3937*×0.115H-0.024A-2.852
ECSC
10 0.0576H-0.0260A-4.340   0.0443H-0.0260A-2.890
Knudson, et al.
11 0.0844H-0.0298A-8.7818 0.0427H-0.0174A-2.901
Paoletti, et al.
9 0.0724H-0.0273A-6.382 0.0412H-0.0154A-2.329
Crapo, et al.
12 0.0600H-0.0214A-4.650 0.0491H-0.0216A-3.590
Roca, et al.
8 0.0678H-0.0147A-6.055 0.0454H-0.0211A-2.825
FEV1 (male) FEV1 (female)
Korean
6  0.04578H-0.0002484A²-3.4132 0.03558H-0.0001920A²-2.4114
Morris, et al.
5 0.3937*×0.092H-0.032A-1.260 0.3937*×0.089H-0.025A-1.932
ECSC
10 0.0430H-0.0290A-2.490  0.0395H-0.0250A-2.600
Knudson, et al.
11 0.0665H-0.0292A-6.5147 0.0309H-0.0201A-1.4050
Paoletti, et al.
9 0.0494H-0.0275A-3.576 0.0243H-0.0196A-0.282
Crapo, et al.
12 0.0414H-0.0244A-2.190 0.0342H-0.0255A-1.578
Roca, et al.
8 0.0514H-0.0216A-3.955 0.0326H-0.0253A-1.286
ECSC, European Coal and Steel Community; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; H, height (cm); A, 
age (years); W, weight (kg).
*A conversion factor from inches to centimeters. Application of a New Spirometric Reference Equation for Korean COPD Patients
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classified into GOLD stage 2 or 3 irrespective of the refer-
ence equation used. Interestingly, 15.4% of the study subjects 
were classified as GOLD stage 4 after adopting the new Ko-
rean equation. This figure is the highest among the equations.  
We also evaluated changes in the GOLD stages after ap-
plying the new Korean reference equation, which were ini-
tially obtained from other reference equations. The changes 
in GOLD stages occurred in 18.6% to 49.4% of the sub-
jects. Most were moved into more severe stages (Fig. 1).  
Comparison between the new Korean equation and 
Morris’ equation
The mean FEV1 and FVC of the predicted values were 58.9± 
22.2% and 88.2±21.3% respectively, when using Morris’ 
equation. When the new Korean equation was applied, the 
values of FEV1 and FVC of the predicted value decreased 
to 49.7±18.7% and 76.6±18.3%, respectively. The numbers 
of COPD patients of each stage are illustrated in Fig. 2. 
A total of 143 subjects (32.4%) were classified differently 
in their GOLD stages after application of the new Korean 
equation when compared with Morris’ equation (Table 3). 
the change of disease severity by comparing them with the 
new Korean equation. A p-value of <0.05 was considered 
statistically significant.
 
RESULTS
 
A total 819 subjects were initially screened as having pre-
bronchodilator FEV1/FVC <0.7. After meticulous review of 
chest radiographies by five pulmonologists, a total of 203 sub-
jects were excluded. Then, subjects without post-bronchodila-
tor spirometry results were excluded. A total of 441 subjects 
were enrolled in this study in the end (male : female=379 : 
62). The median age of the subjects was 68 year of age (range 
40-100 years). The mean values of FEV1 and FVC in men 
were 1.47±0.60 L and 2.99±0.90 L, respectively. 
Distribution of the severity of airflow obstruction 
according to each reference equation  
The GOLD stages of the study subjects according to each 
reference equation are shown in Table 2. Most of them were 
Table 2. Distribution of GOLD Stages according to Each Equation (%)
Stage 1 Stage 2 Stage 3 Stage 4     
Korean
6    6.8 40.8 37.0 15.4
Morris, et al.
5*  17.9 44.4 29.8   8.8
ECSC
10*  18.6 46.3 29.5   5.7
Knudson, et al.
11* 25.2 43.3 26.5   5.0
Paoletti, et al.
9* 14.5 44.7 32.9   7.9
Crapo, et al.
12   9.3 46.0 34.2 10.4
Roca, et al.
8   7.7 46.0 34.5 11.8
ECSC, European Coal and Steel Community.
*p value<0.01.
Fig. 1. Changes of COPD stage after application of the newly developed Korean equation. COPD, chronic obstructive pulmonary disease; 
ECSC, European Coal and Steel Community. 
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stages obtained by traditional reference equations, especial-
ly Morris’ equation. This change occurred in 32.4% of COPD 
patients. All patients were reallocated into more severe stag-
es. Therefore, the proportion of severe to very severe pa-
tients was changed from 38.6% to 52.4% (Table 2). This 
finding is contrary to the conventional concept that Asian 
spirometry values are lower than European-Americans,14,15 
but is predictable because the normal value from the new 
Korean reference equation is greater than that of Morris’ 
equation.6 Similar results were found for the GOLD stages 
obtained by other reference equations (Fig. 1). These find-
ings confirm the importance of reference equations for indi-
vidual ethnicities. 
In 2001, a new Korean reference equation for spirometry 
was developed in the Korean NHANES II;6 however, this 
new equation is not used routinely in practice and is used 
only for research purposes. A detailed review of the factors 
explaining why the new Korean equation is not used rou-
tinely, however, was beyond the scope of this study. To our 
knowledge, this study was the first to compare the different 
reference equations for spirometry in COPD patients in Ko-
rea. Oh, et al.16 reported that the application of the newly 
developed Korean equation affected the interpretation of 
the spirometric data. They found that 23.2% of subjects 
were interpreted differently after application of the new Ko-
rean equation. Their study included a large number of 
healthy subjects who performed spirometry for the purpose 
of preoperative screening. Taking in consideration these re-
sults altogether, it showed indirectly that application of 
equations from different ethnic groups did not sufficiently 
reflect pulmonary function, especially in diseased persons. 
We used the fixed ratio of post-bronchodilator FEV1/FVC 
less than 0.7 for the diagnosis of COPD. However, because 
the process of aging does affect lung volumes, there has 
All of them were reallocated into more severe stages (49 at 
stage 1, 65 at stage 2, and 29 at stage 3 were changed to stage 
2, stage 3 and stage 4, respectively). 
DISCUSSION
Spirometry is essential for diagnosis of COPD and provides 
a useful description of the severity of pathological changes 
in COPD patients. The spirometry result should be inter-
preted by comparison with reference (predicted) values. 
Predicted values should be obtained from studies of ‘‘nor-
mal’’ or ‘‘healthy’’ subjects with the same anthropometrics 
(e.g. sex, age and height) and, where relevant, ethnic char-
acteristics of the patient being tested.4 Application of differ-
ent reference values in nonasthmatic young adults showed 
a marked difference in both predicted FVC and FEV1.13 It is 
also known that Asian-Americans have a significantly low-
er FVC and FEV1 than European-Americans for the same 
height, independent of level of fitness or length of residence, 
representing a true physiologic difference between ethnici-
ties.14 That being so, there was a concern that the use of ref-
erence equations based on other ethnicities might lead to 
misinterpretation of the spirometric data, especially in a dis-
eased person. We found that the application of the new Ko-
rean reference equation for spirometry changed the GOLD 
Table 3. Changes of GOLD Stages from Morris’ Equation to 
the New Korean Equation
Stage change (n, %) 143 (32.4%)
Up-staging (n, %) 143 (100%)
    Stage 1 → Stage 2    49 (34.3%)
    Stage 2 → Stage 3    65 (45.5%)
    Stage 3 → Stage 4    29 (20.2%)
Down-staging (n, %) 0 (0%)
Fig. 2. Distribution of COPD severity according to the newly developed Korean equation and Morris’ equation. COPD, chronic obstructive 
pulmonary disease.
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